Metropolis Healthcare board to review financials, consider interim dividend

Metropolis Healthcare Limited will convene a Board of Directors meeting on Tuesday, November 04, 2025. The agenda includes the consideration and approval of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025.

Additionally, the board will discuss the declaration of an interim dividend for the financial year 2025-26, if any, on the company's equity shares. This announcement was made under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In adherence to the company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in Metropolis Healthcare securities is closed from October 01, 2025, to November 06, 2025, inclusive of both dates. This measure is implemented to prevent insider trading ahead of the financial results and dividend consideration.